Dermira (NASDAQ: DERM) reported Q3 EPS of $0.99, $1.15 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $34.54 million versus the consensus estimate of $16.9 million.

For earnings history and earnings-related data on Dermira (DERM) click here.